Acutaas Chemicals has made the recording of its earnings call available to investors and stakeholders. The call was held on July 24, 2026, at 4.00 p.m. IST, following an intimation submitted to the exchanges on July 20, 2026. The audio file is accessible via the company’s official website, ensuring transparency and accessibility for market participants seeking insights into the firm’s recent performance and strategic outlook.

The disclosure was filed with the Listing Departments of both the Bombay Stock Exchange (BSE) and the National Stock Exchange of India Limited (NSE). The filing cites compliance with Regulation 30 and Regulation 46(2) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. These regulations mandate timely and accurate dissemination of material information to prevent information asymmetry in the market.

Key Details

The announcement was signed by Ekta Kumari Srivastava, Company Secretary and Compliance Officer of Acutaas Chemicals Limited. The digital signature timestamp indicates the filing was executed on July 24, 2026, at 18:17:57 IST.

Investors can access the recording directly through the link provided in the exchange filing, which directs to a specific resource on the company’s backend server. This direct access method aligns with standard practices for distributing non-public or time-sensitive financial communications under Indian securities law.

What the Numbers Show

As this filing pertains to the availability of an earnings call recording rather than the release of new financial data points such as revenue or profit figures, no quantitative analysis can be derived from this document alone. The material value lies in the subsequent discussion during the call, which investors are expected to review for forward-looking statements and management commentary.

Acutaas Chemicals has come into sharp focus after brokerage firm InCred upgraded the stock to Add with a target price of ₹4,757. The upgrade is backed by a strong Q1FY27 operational performance and a significant business milestone at the company's Jhagadia manufacturing unit.

Strong Q1FY27 Performance Drives Upgrade

InCred's upgrade reflects a robust set of Q1FY27 results for Acutaas Chemicals. The company's EBITDA more than doubled on a year-on-year basis, a performance the brokerage attributes to a combination of gross margin gains and operating leverage. The following table summarizes the key financial highlight from the quarter:

The margin expansion to 34.30% is a notable development, reflecting improved cost efficiencies and a favorable product mix during the quarter.

Electrolyte Additives Business Gains Momentum

Beyond the quarterly financials, InCred also highlighted a significant operational development at Acutaas Chemicals' Jhagadia unit. Commercial supply of electrolyte additives has commenced at the facility, marking an important step in the company's growth strategy.

The key details of the Jhagadia unit development are as follows:

The commencement of commercial supply signals the transition of the electrolyte additives segment from a developmental phase to an active revenue-generating business line. The 4,000 MT of contracted VC and FEC capacity is targeted for utilization over the next three years, providing a structured demand pipeline for the Jhagadia unit.

Analyst Outlook

InCred's upgrade to Add with a target price of ₹4,757 encapsulates both the strong near-term financial delivery and the longer-term growth potential from the electrolyte additives business. The brokerage's assessment underscores the dual drivers of margin improvement in the core business and capacity ramp-up in the specialty chemicals segment at Jhagadia.